MAP3K8/Tpl2/COT Antibody Blocking Peptide

Key Product Details

Product Specifications

Formulation, Preparation, and Storage

Background: MAP3K8/Tpl2/COT

Required for lipopolysaccharide (LPS)-induced, TLR4-mediated activation of the MAPK/ERK pathway in macrophages, thus being critical for production of the proinflammatory cytokine TNF-alpha (TNF) during immune responses. Involved in the regulation of T-helper cell differentiation and IFNG expression in T-cells. Involved in mediating host resistance to bacterial infection through negative regulation of type I interferon (IFN) production. In vitro, activates MAPK/ERK pathway in response to IL1 in an IRAK1-independent manner, leading to up-regulation of IL8 and CCL4. Transduces CD40 and TNFRSF1A signals that activate ERK in B-cells and macrophages, and thus may play a role in the regulation of immunoglobulin production. May also play a role in the transduction of TNF signals that activate JNK and NF-kappa-B in some cell types. In adipocytes, activates MAPK/ERK pathway in an IKBKB-dependent manner in response to IL1B and TNF, but not insulin, leading to induction of lipolysis. Plays a role in the cell cycle. Isoform 1 shows some transforming activity, although it is much weaker than that of the activated oncogenic variant.

Additional MAP3K8/Tpl2/COT Products

• All Products for MAP3K8/Tpl2/COT
• MAP3K8/Tpl2/COT Lysates
• MAP3K8/Tpl2/COT Primary Antibodies
• MAP3K8/Tpl2/COT Proteins and Enzymes

Product Documents for MAP3K8/Tpl2/COT Antibody Blocking Peptide